Evaluation of Myeloid and Lymphoid Regulatory Cell Populations in the Peripheral Blood of Patients Receiving GM-CSF in a Vaccine-Based Immunotherapy Clinical Trial

被引：0

作者：

Olson, Walter C. ^{[1
]}

McSkimming, Chantel ^{[1
]}

Slingluff, Craig L. ^{[1
]}

机构：

[1] Univ Virginia, Charlottesville, VA USA

来源：

JOURNAL OF IMMUNOTHERAPY | 2010年 / 33卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：872 / 873

页数：2

共 50 条

[41] Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine
Matthew T. Hueman
Alexander Stojadinovic
Catherine E. Storrer
Zia A. Dehqanzada
Jennifer M. Gurney
Craig D. Shriver
Sathibalan Ponniah
George E. Peoples
Cancer Immunology, Immunotherapy, 2007, 56 : 135 - 146
[42] Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF
Podaza, Enrique
Carri, Ibel
Aris, Mariana
von Euw, Erika
Bravo, Alicia Ines
Blanco, Paula
Ortiz Wilczynski, Juan Manuel
Koile, Daniel
Yankilevich, Patricio
Nielsen, Morten
Mordoh, Jose
Barrio, Maria Marcela
FRONTIERS IN IMMUNOLOGY, 2020, 11
[43] Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation
J. Vela-Ojeda
M. A. García-Ruiz Esparza
E. Reyes-Maldonado
L. Jiménez-Zamudio
E. García-Latorre
M. Moreno-Lafont
I. Estrada-García
L. Montiel-Cervantes
F. Tripp-Villanueva
M. Ayala-Sánchez
L. D. García-León
J. R. Borbolla-Escoboza
H. Mayani
Annals of Hematology, 2006, 85 : 113 - 120
[44] Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation
Vela-Ojeda, J
Esparza, MAGR
Reyes-Maldonado, E
Jiménez-Zamudio, L
García-Latorre, E
Moreno-Lafont, M
Estrada-García, I
Montiel-Cervantes, L
Tripp-Villanueva, F
Ayala-Sánchez, M
García-León, LD
Borbolla-Escoboza, JR
Mayani, H
ANNALS OF HEMATOLOGY, 2006, 85 (02) : 113 - 120
[45] A phase 1 clinical trial of a PSA/IL-2/GM-CSF containing prostate cancer vaccine in PSA defined biochemical recurrent prostate cancer patients.
Daniels, Gregory A.
McKinney, Michelle
Ongkeko, Weg
Wang-Rodriguez, Jessica
Sakamoto, Kyoko
Elliott, Robert Lange
Head, Jonathan F.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[46] Phase 1 clinical trial of a therapeutic prostate cancer vaccine containing PSA/IL-2/GM-CSF in PSA defined biochemical recurrent prostate cancer patients
Head, Jonathan F.
Daniels, Gregory A.
McKinney, Michelle
Ongkeko, Weg
Wang-Rodriguez, Jessica
Sakamoto, Kyoko
Elliott, Robert L.
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
[47] In vivo regulation of Fas ligand (FasL) expression in peripheral blood lymphocytes (PBL) of patients with relapsed Hodgkin's disease (HD):: Results of a pilot clinical trial of interferon-α and GM-CSF (Ifn+GM) cytokine therapy.
Wang, Y
Asgary, Z
Cabanillas, F
Younes, A
BLOOD, 1998, 92 (10) : 405A - 405A
[48] GM-CSF secreting leukemia cell vaccinations after allogeneic reduced-intensity peripheral blood stem cell transplantation (SCT) for advanced myelodysplastic syndrome (MDS) or refractory acute myeloid leukemia (AML)
Ho, V. T.
Dranoff, G.
Kim, H.
Pasek, M.
Cutler, C.
Koreth, J.
Alyea, E. P.
Antin, J. H.
Soiffer, R. J.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 24 - 24
[49] IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1adim, CD83+ myeloid dendritic cell subset
Roy, KC
Bandyopadhyay, G
Rakshit, S
Ray, M
Bandyopadhyay, S
JOURNAL OF CELL SCIENCE, 2004, 117 (16) : 3435 - 3445
[50] Preliminary results of a phase 1 clinical trial of a PSA, IL-2, GM-CSF containing prostate cancer vaccine in PSA defined biochemical recurrent prostate cancer patients
Head, Jonathan F.
Daniels, Gregory A.
McKinney, Michelle
Ongkeko, Weg
Sakamoto, Kyoko
Wang-Rodriguez, Jessica
CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)

← 1 2 3 4 5 →